CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

VIRVir Biotechnology, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $11.18 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$1.89B
CountryUSA
RECENT INSIDER TRADES
  • 2026-08-12 · MORE ROBERT J (Director) · OTHER
  • 2026-06-10 · Coughlin Timothy (Director) · OTHER
  • 2026-06-02 · Napolitano Janet (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders255
Shares held178,913,737
Value$1.73B
Percent of shares outstanding105.73%
As of quarter end2026-06-30
RECENT NEWS
  • Vir Biotechnology stock hits 52-week high at 11.96 USD
  • H.C. Wainwright raises Vir Biotechnology price target to $22
  • Vir Biotechnology appoints David Liu as chief medical officer
  • Vir Biotechnology appoints new CFO
  • Vir Biotechnology: Astellas Deal Highlights The Platform's Value
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Vir Biotechnology, Inc. (VIR) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit